Log in
FREE 15-Day Trial
Intelligent Investor
Intelligent Investor
  1. Home
  2. Research & Advice
  3. Research Tools
  4. Shares
  5. CSL Limited (CSL)
  6. Company Financials

CSL Limited (ASX: CSL) - Financials

- Current share price for CSL : $271.400

CSL Limited (CSL) is a global biotechnology company that develops and delivers innovative medicines that save lives, protect public health and help people with life-threatening medical conditions live full lives. CSL is also involved in research, development, manufacture, marketing and distribution of biopharmaceutical and allied products. CSL's operating model for its two businesses, CSL Behring and Seqirus.

The Intelligent Investor Australian Equity Income Fund (ASX:INIF), Intelligent Investor Ethical Share Fund (ASX:INES), Intelligent Investor Australian Equity Growth Fund (ASX:IIGF) owns shares in CSL Limited (ASX: CSL)

Intelligent Investor free trial for buy hold sell stock recommendations

CSL Per Share

Year to Jun Sales Cashflow Earnings Dividends Franking Book Value Average
Annual P/E		 Relative P/E Shareholder Return
2023 $41.00 810 ¢ 683.3 ¢ 356 ¢ 5% $49.40 42.8 282.6% 4.3%
2022 $32.40 812.3 ¢ 735.6 ¢ 322.2 ¢ 5% $43.90 38.5 232.1% -4.6%
2021 $30.00 1056.8 ¢ 720.5 ¢ 390.9 ¢ 5% $24.50 39.3 333% 0.4%

CSL Capital Structure

Total Debt Interest Long Term Debt Percent Debt Preferred Stock Share Equity Percent Equity
$18,441,931 $669,683 $16,850,679 41% $0.00 $23,809,955 59%
Note: All dollars in thousands ('000) for the table above

CSL Historical Financials

2023 2022 2021
Revenue ($M) 19,870.3 15,231.7 13,654.3
Operating Margin (%) 29.6 34.4 36.2
Depreciation ($M) -739.1 -647 -531.3
Amortisation ($M) -514 -141 -128
Net Profit Before Abs ($M) 3,309.2 3,455.5 3,284.5
Net Profit After Abs ($M) 3,309.2 3,272.9 3,159.1
Income Tax Rate (%) 15.7 18.9 19.9
Net Profit Margin (%) 16.7 22.7 24.1
Employees ($T) 32 30 25.4
Long Term Debt ($M) 16,850.7 7,495.7 7,093.8
Shareholders Equity ($M) 23,810 21,160.5 11,148.3
Return on Capital (%) 9 13 19
Return on Equity (%) 13.9 16.3 29.5
Payout Ratio (%) 52 44 54

CSL Cashflow

2023 2022 2021
Customer Receipts ($M)
Net Operating Cashflow ($M) 3,923 3,816 4,818
Net Investing Cashflow ($M) -17,863 -2,375 -2,226
Net Financing Cashflow ($M) 688 11,142 -1,865

CSL Market & Earnings

2023 2022 2021
Market Cap ($M) 133,800 129,608 129,797
Net Gearing (%) 59.9 -5.3 47.7
Net Interest Cover (%) 7.56 19.09 19.32
Dividend Yield (%) 1.3 1.2 1
NTA Per Share ($) -2.06 35.98 16.69
EBITDA ($M) 5,882 5,238 4,948
EBIT ($M) 4,629 4,451 4,289
EBT Before Abs ($M) 4,017 4,217 4,067

CSL Balance Sheet

2023 2022 2021
Cash ($M) 2,335 15,149 2,406
Debtors ($M) 2,130 1,377 1,295
Other Debtors ($M) 743.6 775.6 785
Prepayments ($M) 452.5 252.6 196.2
Inventories ($M) 8,244 6,290 5,029
Current Investments ($M)
Other Current Assets ($M) 60.3 49.5 118.5
Total Current Assets ($M) 13,965 23,894 9,829
Receivables ($M) 144.8 18.58 8.78
Inventories ($M)
Property, Plant & Equipment ($M) 19,336 16,636 13,792
Accumulated Depreciation ($M) -5,231 -4,575 -3,768
Intangibles ex. Goodwill ($M) 12,620 2,106 1,971
Goodwill ($M) 12,186 1,723 1,580
Future Income Tax Benefit ($M) 1,360.5 751.2 704.3
Non-Current Investments ($M) 260.9 584.8 28.6
Other Non-Current Assets ($M) 9.05 7.84 5.19
Total Non-Current Assets ($M) 40,686 17,253 14,322
Total Assets ($M) 54,652 41,147 24,151
Accounts Payable ($M) 4,445 3,340 2,713
Provisions ($M) 914 454.3 718.8
Short Term Debt ($M) 1,591.3 6,523.4 630.2
Other Current Liabilities ($M) 66.1
Total Current Liabilities ($M) 6,950 10,318 4,128
Creditors ($M) 596
Long Term Debt ($M) 16,851 7,496 7,094
Provisions ($M) 3,220 1,395 1,135
Other Non-Current Liabilities ($M) 743.6 777.6 49.5
Total Non-Current Liabilities ($M) 20,814 9,668 8,875
Total Liabilities ($M) 27,765 19,986 13,003
Share Capital ($M) 779.8 702.3 -5,991.8
Reserves ex. Share Premium ($M) 977.4 856.9 842.2
Share Premium Reserve ($M)
Retained Profits ($M) 22,053 19,601 16,298
Other Shareholders Equity ($M)
Convertible Equity ($M)
Outside Equity Interest ($M) 3,077
Total Shareholders Equity ($M) 26,887 21,161 11,148

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.